Research Article
The In Vitro Antimicrobial Activity of Lavandula angustifolia Essential Oil in Combination with Other Aroma-Therapeutic Oils
Table 2
The antimicrobial effects of L. angustifolia essential oil against 14 test pathogens.
| | Microorganism | Reference strain no. | MIC* |
| | Methicillin-resistant Staphylococcus aureus (MRSA) | ATCC 43300 | 2.00 | | Methicillin-resistant Staphylococcus aureus | Clinical strain | 2.00 | | Methicillin-gentamicin resistant Staphylococcus aureus (MGRSA) | ATCC 33592 | 2.00 | | Staphylococcus aureus | ATCC 6538 | 2.00 | | Staphylococcus aureus | Clinical strain | 2.00 | | Staphylococcus epidermidis | ATCC 2223 | 2.00 | | Staphylococcus epidermidis | Clinical strain | 2.00 | | Vancomycin-resistant Enterococcus faecalis | ATCC 51299 | 2.00 | | Enterococcus faecalis | Clinical strain | 2.00 | | Klebsiella pneumoniae | ATCC 13883 | 1.50 | | Pseudomonas aeruginosa | ATCC 27853 | 2.00 | | Cryptococcus neoformans | ATCC 11093 | 2.00 | | Candida tropicalis | ATCC 201380 | 0.75 | | Candida albicans | ATCC 10231 | 3.00 | | Ciprofloxacin | Positive control | 0.20 × 10−3 to 0.60 × 10−3 | | Amphotericin B | Positive control | 0.60 × 10−3 |
|
|
*MIC given in mg/mL.
|
